Entry |
|
Name |
Fleroxacin (JAN/USAN/INN); Megalocin (TN); Megalone (TN) |
Abbr |
FLE |
Formula |
C17H18F3N3O3
|
Exact mass |
369.13
|
Mol weight |
369.3383
|
Structure |
|
Simcomp |
|
Class |
|
Remark |
|
Efficacy |
Antibacterial, Nucleic acid biosynthesis inhibitor |
Target |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA08 Fleroxacin
D01716 Fleroxacin (JAN/USAN/INN)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
D01716 Fleroxacin
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D01716 Fleroxacin (JAN/USAN/INN)
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D01716 Fleroxacin (JAN/USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 26
1 C8y C 32.4934 -13.8608
2 C8y C 32.4865 -15.2627
3 N4y N 33.6981 -15.9735
4 C8x C 34.9168 -15.2751
5 C8y C 34.9239 -13.8730
6 C8y C 33.7123 -13.1693
7 C8y C 30.0700 -13.8608
8 C8y C 30.0700 -15.2627
9 C8y C 31.2879 -15.9674
10 C8x C 31.2879 -13.1632
11 N1y N 28.8580 -15.9645
12 C1x C 27.6424 -15.2605
13 C1x C 26.4345 -15.9657
14 N1y N 26.4353 -17.3678
15 C1x C 27.6439 -18.0648
16 C1x C 28.8586 -17.3665
17 O5x O 33.7426 -11.7672
18 C6a C 36.1357 -13.1814
19 O6a O 37.3471 -13.8851
20 O6a O 36.1426 -11.7793
21 X F 28.8510 -13.1632
22 X F 31.2745 -17.3695
23 C1a C 25.2155 -18.0529
24 C1b C 33.6843 -17.3624
25 C1b C 34.8780 -18.0676
26 X F 36.0868 -17.3855
BOND 28
1 1 2 2
2 2 3 1
3 11 12 1
4 12 13 1
5 13 14 1
6 14 15 1
7 15 16 1
8 16 11 1
9 8 11 1
10 3 4 1
11 6 17 2
12 7 8 1
13 5 18 1
14 8 9 2
15 18 19 1
16 9 2 1
17 18 20 2
18 1 10 1
19 7 21 1
20 10 7 2
21 9 22 1
22 4 5 2
23 14 23 1
24 5 6 1
25 3 24 1
26 6 1 1
27 24 25 1
28 25 26 1
|